Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma [7]

Hepatology

Volumn 47, Issue 1, 2008, Pages 357-

  Sangiovanni, Angelo ^a   Iavarone, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER RISK; COMORBIDITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ITALY; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

CARCINOMA, HEPATOCELLULAR; GENOTYPE; HEPACIVIRUS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; RISK FACTORS;

EID: 38649098458     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22060     Document Type: Letter

References (5)

1. Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. HEPATOLOGY 2007;46. DOI: 10.1002/hep.21826.
2. Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. HEPATOLOGY 2006;43:1303-1310.
3. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127:S35-S50.
4. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al., for the EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-430.
5. Bruix J, Sherman M. Management of hepatocellular carcinoma. HEPATOLOGY 2005;42:1208-1236.